Flatiron Health appointed Michael Bierl as Chief Business Officer, Allison Candido as Chief Technology Officer, and Kate Estep as Chief Product Officer.
Michael Bierl joined in 2019, leads global commercial, scientific, clinical, operational, and customer-facing teams.
Allison Candido has been with Flatiron since 2014, leads Engineering with focus on AI and data scale.
Kate Estep joined in 2018, drives evolution of Point of Care and Global Evidence product suites.
These appointments reflect Flatiron's strategy to build an integrated global platform for oncology.
Nathan Hubbard, CEO, highlighted the leaders' roles in transforming cancer care.